OTCFF (Ocumetics Technology) EBITDA Margin %: 0.00% (As of Mar. 2026)


OTCFF Ocumetics Technology Corp OTCFF
30 GF Score
Price $0.32
! 2 Warning Signs
View Full Analysis

What is Ocumetics Technology EBITDA Margin %?

Ocumetics Technology OTCFF -13.78% 30 EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus rates OTCFF with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Ocumetics Technology ranks worse than 122398.9% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ocumetics Technology's EBITDA for the three months ended in Mar. 2026 was $-0.72 Mil. Ocumetics Technology's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Ocumetics Technology's EBITDA margin for the quarter that ended in Mar. 2026 was 0.00%.


Ocumetics Technology  (OTCPK:OTCFF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Ocumetics Technology EBITDA Margin % Related Terms


Ocumetics Technology EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Ocumetics Technology's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocumetics Technology EBITDA Margin % Chart

Ocumetics Technology Annual Data
Trend Jul20 Jul21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Ocumetics Technology Quarterly Data
Jul21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OTCFF vs ISRG, BDX, MDLN: EBITDA Margin % Comparison

For the Medical Instruments & Supplies subindustry, Ocumetics Technology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocumetics Technology EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ocumetics Technology's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Ocumetics Technology's EBITDA Margin % falls into.


OTCFF
30GF Score
Ocumetics Technology Corp OTCFF
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ocumetics Technology EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Ocumetics Technology's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-2.805/0
= %

Ocumetics Technology's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.723/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Ocumetics Technology (OTCFF) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ocumetics Technology and its competitors. According to the industry distribution chart, Ocumetics Technology ranks #999999 out of 817 companies in the Medical Devices & Instruments industry.
Is Ocumetics Technology's EBITDA Margin % too high?
Ocumetics Technology's current EBITDA Margin % is 0.00%. Based on the distribution chart, Ocumetics Technology ranks #999999 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ocumetics Technology has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Ocumetics Technology's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ocumetics Technology ranks #999999 out of 817 companies for EBITDA Margin %. This places Ocumetics Technology in the lower half of its industry. The industry median EBITDA Margin % is 7.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.44, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ocumetics Technology and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ocumetics Technology's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocumetics Technology stock overvalued right now?
Ocumetics Technology (OTCFF) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Ocumetics Technology's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ocumetics Technology (OTCFF), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ocumetics Technology Business Description

Other Exchanges 2QB0:GermanyOTC:Canada
Address 639 - 5th Avenue SW, Suite 1250, Calgary, AB, CAN, T2P 0M9
Ocumetics Technology Corp is a Canadian research and product development company that specializes in adaptive lens designs. The company is engaged in developing an accommodating intraocular lens to eliminate the need for corrective lenses. The company is in the process of developing new lens technology, which is expected to link nerve impulses with the natural mechanisms for accommodation within the human eye.
30GF Score

Get the complete analysis for OTCFF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.32
Price